Santos, António J. M.
van Unen, Vincent http://orcid.org/0000-0001-9339-8430
Lin, Zhongqi http://orcid.org/0000-0002-4806-0091
Chirieleison, Steven M. http://orcid.org/0000-0002-3997-5652
Ha, Nhi http://orcid.org/0000-0001-5782-0921
Batish, Arpit
Chan, Joshua E. http://orcid.org/0000-0002-6016-1397
Cedano, Jose
Zhang, Elisa T.
Mu, Qinghui
Guh-Siesel, Alexander
Tomaske, Madeline
Colburg, Deana
Varma, Sushama
Choi, Shannon S.
Christophersen, Asbjørn
Baghdasaryan, Ani
Yost, Kathryn E. http://orcid.org/0000-0001-6807-950X
Karlsson, Kasper
Ha, Andrew
Li, Jing
Dai, Hongjie
Sellers, Zachary M. http://orcid.org/0000-0001-5352-7760
Chang, Howard Y. http://orcid.org/0000-0002-9459-4393
Dunn, James C. Y. http://orcid.org/0000-0002-6826-7065
Zhang, Bing M.
Mellins, Elizabeth D. http://orcid.org/0000-0003-2577-139X
Sollid, Ludvig M. http://orcid.org/0000-0001-8860-704X
Fernandez-Becker, Nielsen Q.
Davis, Mark M. http://orcid.org/0000-0001-6868-657X
Kuo, Calvin J. http://orcid.org/0000-0002-7427-5985
Article History
Received: 4 April 2022
Accepted: 14 June 2024
First Online: 24 July 2024
Competing interests
: C.J.K. and A.J.M.S. are inventors on patent WO 2020/247528 describing methods and uses of patient-derived celiac intestinal organoids. C.J.K. and M.M.D. are founders of Mozart Therapeutics and NextVivo, Inc. L.M.S has been a consultant during the last 3 years for BMS, GSK, Mozart Therapeutics, Ono Pharmaceutical, Precigen ActoBio, Sanofi-Aventis, SQZ Biotech, Takeda and Topas Therapeutics. All other authors declare no competing interests.